Sign inJoin waitlistJoin the waitlist

Augusto Ochoa

Deputy Director, LSU LCMC Health Cancer Center · Louisiana State University School of Medicine

Credentials: · ·

History

LSU LCMC Health Cancer Center · Louisiana State University School of Medicine
Present
Louisiana State University School of Medicine
Present

Cardiovascular Disease
Internal Medicine

Research

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Review · Nature Communications · 2016 · 2,341 citations
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
Cancer Research · 2004 · Last of 13 authors · 1,043 citations
L-arginine availability regulates T-lymphocyte cell-cycle progression
Blood · 2007 · Last of 3 authors · 738 citations

DL
Dan Longo
15 papers
FB
Fritz Bach
15 papers
Juan Ochoa
12 papers
Peter Anderson
10 papers · 2 as a fellow
Emmanuel Katsanis
7 papers · 5 as a fellow
VS
Victoria Seewaldt
7 papers
Brendan Curti
6 papers
BG
Barry Gause
5 papers
Bruce Blazar
5 papers
PC
Pelayo Correa
5 papers
WU
Walter Urba
5 papers
CP
Christopher Parsons
4 papers

Grants

Gulf South Clinical Trials Network (Gulf South NCORP)
National Cancer Institute · UG1
Contact PI · $27.1M · Lsu Health Sciences Center
2014–2027
Louisiana Clinical and Translational Science Center
National Institute of General Medical Sciences · U54
Project lead · $4M · Lsu Pennington Biomedical Research Ctr
2012–2027
Center for Translational Viral Oncology (CTVO)
National Institute of General Medical Sciences · P20
Project lead · $663.9K · Lsu Health Sciences Center
2017–2027
Understanding and Addressing Cancer Health Disparities in Louisiana
National Cancer Institute · P20
Contact PI · $2.9M · Lsu Health Sciences Center
2018–2022

Clinical trials

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Site PI · Recruiting · Phase 2, Phase 3
NRG Oncology
2022–2030
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2022–2027
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Site PI · Recruiting · Phase 3
NRG Oncology
2021–2041
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Site PI · Recruiting
SWOG Cancer Research Network
2018–2036